Last reviewed · How we verify

NCT05887362

The Power of Hand Reflexology in Ameliorating Anxiety, Pain, and Fatigue Among Patients Undergoing Coronary Angiography

Completed NA Last updated 2 June 2023
What this trial tests

NA trial testing Hand Reflexology in Coronary Artery Disease in 60 participants. Completed in 15 November 2022.

Timeline
1 July 2022
Primary endpoint
1 November 2022
15 November 2022

Quick facts

Lead sponsorAlexandria University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment60
Start date1 July 2022
Primary completion1 November 2022
Estimated completion15 November 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Alexandria University

Who can join

Adults 20 to 60, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Reflexology influences pain perception and pain-impulse transmission by releasing endorphins (12). Patients with a variety of medical illnesses can benefit from hand reflexology by lessening their physical and emotional discomfort (13, 14). Therefore, this study was done to investigate the power of hand reflexology in ameliorating anxiety, pain, and fatigue among patients undergoing coronary angiography

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of hand reflexology in ameliorating anxiety, pain, and fatigue among patients undergoing coronary angiography.
    Ali EA, Awad WHA, Khedr MA, Rabie EAEGA. · · 2023 · cited 5× · PMID 38001461 · DOI 10.1186/s12906-023-04256-6

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

Other Alexandria University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05887362.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing